| Trial ID: | L7054 |
| Source ID: | NCT00044447
|
| Associated Drug: |
Glimepiride
|
| Title: |
Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Non-Insulin-Dependent
|
| Interventions: |
DRUG: Glimepiride
|
| Outcome Measures: |
Primary: Change in HbA1C from baseline to Week 26. | Secondary: Incidence of hypoglycemia.
|
| Sponsor/Collaborators: |
Sponsor: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
170
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2001-05
|
| Completion Date: |
2002-09
|
| Results First Posted: |
|
| Last Update Posted: |
2008-06-19
|
| Locations: |
Dallas Diabetes & Endocrine Center, Dallas, Texas, 75230, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00044447
|
